Tag: maleBreastCancer

Male breast cancer: Breast cancer in men. Most male breast cancer appears to resemble female postmenopausal hormone receptor positive (ER+/PR+) breast cancer. Rates of male breast cancer have been increasing along with exposure to estrogen in our diets and from various industrial and environmental sources.

Articles

News

01/10/12: Father's breast cancer or BRCA mutation influences daughter's risk
12/27/11: Breast cancer in male and female relatives increases risk of BC

Studies

Endocrine Hormones and Their Impact on Pubertal Gynecomastia Cite
Shi Z, Xin M. Endocrine Hormones and Their Impact on Pubertal Gynecomastia. MDPI AG; 2024; 10.20944/preprints202411.0119.v1
Second Primary Cancer Risks After Breast Cancer in BRCA1 and BRCA2 Pathogenic Variant Carriers Cite
Allen I, Hassan H, Walburga Y, Huntley C, Loong L, Rahman T, et al. Second Primary Cancer Risks After Breast Cancer in BRCA1 and BRCA2 Pathogenic Variant Carriers. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2024; 10.1200/jco.24.01146
Clinical characteristics of male patients with breast cancer in the Latino population Cite
González-Nuñez C, Mohar A, Reynoso-Noverón N, Alvarez-Gómez RM, Chavarri-Guerra Y, Aguilar-Villanueva S, et al. Clinical characteristics of male patients with breast cancer in the Latino population. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2024; 10.1007/s10549-024-07525-1
The Role of Adjuvant Radiotherapy in Low-Risk Elderly Male Breast Cancer: Is Omission Justified? Cite
Xu C, Zeng C, Meng H, Ma F. The Role of Adjuvant Radiotherapy in Low-Risk Elderly Male Breast Cancer: Is Omission Justified?. Springer Science and Business Media LLC; 2024; 10.21203/rs.3.rs-5285916/v1
Cancer Incidence among Marines and Navy Personnel and Civilian Workers Exposed to Industrial Solvents in Drinking Water at US Marine Corps Base Camp Lejeune: A Cohort Study Cite
Bove FJ, Greek A, Gatiba R, Kohler B, Sherman R, Shin GT, et al. Cancer Incidence among Marines and Navy Personnel and Civilian Workers Exposed to Industrial Solvents in Drinking Water at US Marine Corps Base Camp Lejeune: A Cohort Study. Environmental Health Perspectives. Environmental Health Perspectives; 2024; 132 10.1289/ehp14966
Estrogen receptors, hormonal imbalance, gynecomastia, hyperestrogenemia, and male breast cancer: a literature review Cite
. Estrogen receptors, hormonal imbalance, gynecomastia, hyperestrogenemia, and male breast cancer: a literature review. Journal of Men's Health. MRE Press; 2024; 10.22514/jomh.2024.143
Unveiling the comorbidity burden of male breast cancer Cite
Santos-Mejías A, Moreno-Juste A, Laguna-Berna C, Poblador-Plou B, Aparicio-Lopéz D, Franco MCC, et al. Unveiling the comorbidity burden of male breast cancer. Scientific Reports. Springer Science and Business Media LLC; 2024; 14 10.1038/s41598-024-73032-4
Trends in Incidence, Treatment Patterns and Genomic Testing Utilization among Male Breast Cancer Patients Using the OneFlorida Database Cite
Casper A, Hong Y, Bradley J, Oladeru O. Trends in Incidence, Treatment Patterns and Genomic Testing Utilization among Male Breast Cancer Patients Using the OneFlorida Database. International Journal of Radiation Oncology*Biology*Physics. Elsevier BV; 2024; 120:e300 10.1016/j.ijrobp.2024.07.666
Breast Cancer-Related Chemical Exposures in Firefighters Cite
Cardona B, Rodgers KM, Trowbridge J, Buren H, Rudel RA. Breast Cancer-Related Chemical Exposures in Firefighters. Toxics. MDPI AG; 2024; 12:707 10.3390/toxics12100707
Postmarketing adverse events of tamoxifen in male and female patients with breast cancer Cite
Ke C, Chen M, Lin L, Huang Y. Postmarketing adverse events of tamoxifen in male and female patients with breast cancer. International Journal of Cancer. Wiley; 2024; 10.1002/ijc.35193
BRCA1, BRCA2, and Associated Cancer Risks and Management for Male Patients Cite
Cheng HH, Shevach JW, Castro E, Couch FJ, Domchek SM, Eeles RA, et al. BRCA1, BRCA2, and Associated Cancer Risks and Management for Male Patients. JAMA Oncology. American Medical Association (AMA); 2024; 10.1001/jamaoncol.2024.2185
Influence of tumour grade on disease survival in male breast cancer patients: a systematic review Cite
Kinsey-Trotman S, Nguyen A, Edwards S, Swalling A, Dasari P, Walsh D, et al. Influence of tumour grade on disease survival in male breast cancer patients: a systematic review. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2024; 10.1007/s10549-024-07446-z
Mortality and hospitalization in italian contaminated sites with petrochemical and steel plants: a meta-regression analysis Cite
Minichilli F, Manno V, Bustaffa E, Benedetti M, Contiero P, Iavarone I, et al. Mortality and hospitalization in italian contaminated sites with petrochemical and steel plants: a meta-regression analysis. ISEE Conference Abstracts. Environmental Health Perspectives; 2024; 2024 10.1289/isee.2024.0959
BRCA1, BRCA2, and Associated Cancer Risks and Management for Male Patients Cite
Cheng HH, Shevach JW, Castro E, Couch FJ, Domchek SM, Eeles RA, et al. BRCA1, BRCA2, and Associated Cancer Risks and Management for Male Patients. JAMA Oncology. American Medical Association (AMA); 2024; 10.1001/jamaoncol.2024.2185
Genomic profiling and comparative analysis of male versus female metastatic breast cancer across subtypes Cite
Kadamkulam Syriac A, Nandu NS, Clark A, Tavallai M, Jin DX, Sokol E, et al. Genomic profiling and comparative analysis of male versus female metastatic breast cancer across subtypes. Breast Cancer Research. Springer Science and Business Media LLC; 2024; 26 10.1186/s13058-024-01872-z
Survival pattern in male breast cancer: distinct from female breast cancer Cite
Gwark S, Kim J, Chung IY, Kim HJ, Ko BS, Lee JW, et al. Survival pattern in male breast cancer: distinct from female breast cancer. Frontiers in Oncology. Frontiers Media SA; 2024; 14 10.3389/fonc.2024.1392592
Gynecomastia in adolescent males: current understanding of its etiology, pathophysiology, diagnosis, and treatment Cite
Metwalley KA, Farghaly HS. Gynecomastia in adolescent males: current understanding of its etiology, pathophysiology, diagnosis, and treatment. Annals of Pediatric Endocrinology & Metabolism. Korean Society of Pediatric Endocrinology; 2024; 29:75-81 10.6065/apem.2346142.071
BRCA-associated hereditary male cancers: can gender affect the prevalence and spectrum of germline pathogenic variants? Cite
Fanale D, Corsini LR, Brando C, Randazzo U, Bono M, Pedone E, et al. BRCA-associated hereditary male cancers: can gender affect the prevalence and spectrum of germline pathogenic variants?. Frontiers in Oncology. Frontiers Media SA; 2024; 14 10.3389/fonc.2024.1414343
Male breast cancer: a multicenter study to provide a guide for proper management Cite
Lissidini G, Nicosia L, Sargenti M, Cucchi MC, Fabi A, Falco G, et al. Male breast cancer: a multicenter study to provide a guide for proper management. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2024; 10.1007/s10549-024-07380-0
Deciphering the molecular landscape: evolutionary progression from gynecomastia to aggressive male breast cancer Cite
Yang C, Wang Z, Qian L, Fu J, Sun H. Deciphering the molecular landscape: evolutionary progression from gynecomastia to aggressive male breast cancer. Cellular Oncology. Springer Science and Business Media LLC; 2024; 10.1007/s13402-024-00964-4
The experience of men with breast cancer: a metasynthesis Cite
Guarinoni MG, Motta PC. The experience of men with breast cancer: a metasynthesis. Journal of Public Health. Springer Science and Business Media LLC; 2024; 10.1007/s10389-024-02307-x
Ki67 as a prognostic factor in male breast cancer (male BC): Results from a large GEICAM Spanish cohort of male BC. Cite
Urruticoechea A, Martinez P, Hernando C, Recalde S, Sanchez Munoz A, Morales D, et al. Ki67 as a prognostic factor in male breast cancer (male BC): Results from a large GEICAM Spanish cohort of male BC.. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2024; 42:556-556 10.1200/jco.2024.42.16_suppl.556
Mammographically and sonographically occult male DCIS seen only on breast MRI Cite
Osei K, Panigrahi B. Mammographically and sonographically occult male DCIS seen only on breast MRI. Radiology Case Reports. Elsevier BV; 2024; 19:3390-3393 10.1016/j.radcr.2024.05.006
Imaging the Male Breast: Gynecomastia, Male Breast Cancer, and Beyond Cite
Mannix J, Duke H, Almajnooni A, Ongkeko M. Imaging the Male Breast: Gynecomastia, Male Breast Cancer, and Beyond. RadioGraphics. Radiological Society of North America (RSNA); 2024; 44 10.1148/rg.230181
Conditional survival of male breast cancer Cite
Fan Y, Ku C, Wang R, Wu B, Cui M, Wang J, et al. Conditional survival of male breast cancer. European Journal of Cancer Prevention. Ovid Technologies (Wolters Kluwer Health); 2024; 10.1097/cej.0000000000000893
Male breast cancer differs from female breast cancer in molecular features that affect prognoses and drug responses Cite
Li Y, Guo Y, Chen F, Cui Y, Chen X, Shi G. Male breast cancer differs from female breast cancer in molecular features that affect prognoses and drug responses. Translational Oncology. Elsevier BV; 2024; 45:101980 10.1016/j.tranon.2024.101980
Abstract PO1-16-10: BRCA mutated Male Breast Cancer, hallmarks of a distinct disease. Data from the Spanish Male Breast Cancer Registry (GEICAM/2016-04) Cite
Martínez-Jáñez N, Martínez P, Hernando C, Recalde S, Sánchez A, Morales D, et al. Abstract PO1-16-10: BRCA mutated Male Breast Cancer, hallmarks of a distinct disease. Data from the Spanish Male Breast Cancer Registry (GEICAM/2016-04). Cancer Research. American Association for Cancer Research (AACR); 2024; 84:PO1-16-10-PO1-16-10 10.1158/1538-7445.sabcs23-po1-16-10
Abstract PO2-09-09: Racial/Ethnic Differences in Survival of Male Patients with Stage I-III Breast Cancer by Hormone Receptor Status Using Real-World Data Cite
Freeman J, Hara J, Omoleye O, Li J, Guo W. Abstract PO2-09-09: Racial/Ethnic Differences in Survival of Male Patients with Stage I-III Breast Cancer by Hormone Receptor Status Using Real-World Data. Cancer Research. American Association for Cancer Research (AACR); 2024; 84:PO2-09-09-PO2-09-09 10.1158/1538-7445.sabcs23-po2-09-09
Abstract PO2-10-03: Clinical characteristics and survival trends of male breast cancer in the United States: A propensity score matched analysis Cite
Roy AM, George A, Patel A, Alharbi M, Attwood K, Gandhi S. Abstract PO2-10-03: Clinical characteristics and survival trends of male breast cancer in the United States: A propensity score matched analysis. Cancer Research. American Association for Cancer Research (AACR); 2024; 84:PO2-10-03-PO2-10-03 10.1158/1538-7445.sabcs23-po2-10-03
Evaluation of mortality among Marines, Navy personnel, and civilian workers exposed to contaminated drinking water at USMC Base Camp Lejeune: a cohort study Cite
Bove FJ. Evaluation of mortality among Marines, Navy personnel, and civilian workers exposed to contaminated drinking water at USMC Base Camp Lejeune: a cohort study. Research Square Platform LLC; 2024; 10.21203/rs.3.rs-4171975/v1
HER2 Low Expression in Primary Male Breast Cancer Cite
Nobbe K, Erices-Leclercq M, Foerster F, Förster R, Baldus S, Rudlowski C, et al. HER2 Low Expression in Primary Male Breast Cancer. Breast Cancer: Targets and Therapy. Informa UK Limited; 2024; Volume 16:141-148 10.2147/bctt.s450682
Adjuvant chemotherapy and survival in males aged 70 years or older with breast cancer: a population-based retrospective study Cite
Yu Y, Huang K, Liu Y, Chen R, Yu X, Song C. Adjuvant chemotherapy and survival in males aged 70 years or older with breast cancer: a population-based retrospective study. BMC Geriatrics. Springer Science and Business Media LLC; 2024; 24 10.1186/s12877-024-04861-1
The incidence of male breast cancer in Klinefelter’s syndrome and its proposed mechanisms Cite
Cook B, Nayar S. The incidence of male breast cancer in Klinefelter’s syndrome and its proposed mechanisms. European Journal of Cancer. Elsevier BV; 2024; 200:113885 10.1016/j.ejca.2024.113885
Survival Analysis of Male Patients with Brain Metastases at Initial Breast Cancer Diagnosis over the Last Decade Cite
Avila J, Leone J, Vallejo CT, Leone JP. Survival Analysis of Male Patients with Brain Metastases at Initial Breast Cancer Diagnosis over the Last Decade. Medical Sciences. MDPI AG; 2024; 12:15 10.3390/medsci12010015
Treatment and Prognosis of Male Breast Cancer: A Multicentric, Retrospective Study Over 11 Years in the Czech Republic Cite
Bielcikova Z, Holanek M, Selingerova I, Sorejs O, Kolarova I, Soumarova R, et al. Treatment and Prognosis of Male Breast Cancer: A Multicentric, Retrospective Study Over 11 Years in the Czech Republic. The Oncologist. Oxford University Press (OUP); 2024; 10.1093/oncolo/oyae031
Accuracy of sentinel lymph node biopsy in male breast cancer: Systematic review and meta-analysis Cite
Parpex G, Ottaviani M, Lorphelin H, Mezzadri M, Marchand E, Cahen-Doidy L, et al. Accuracy of sentinel lymph node biopsy in male breast cancer: Systematic review and meta-analysis. The Breast. Elsevier BV; 2024;:103703 10.1016/j.breast.2024.103703
Mortality Risks Over 20 Years in Men With Stage I to III Hormone Receptor–Positive Breast Cancer Cite
Leone J, Hassett MJ, Freedman RA, Tolaney SM, Graham N, Tayob N, et al. Mortality Risks Over 20 Years in Men With Stage I to III Hormone Receptor–Positive Breast Cancer. JAMA Oncology. American Medical Association (AMA); 2024; 10.1001/jamaoncol.2023.7194
Male Invasive Lobular Breast Cancer: Clinicopathologic Features Including Recurrence Score Results From a Population-Based Database Cite
Balatico M, Ruano AL, Cleary AS, Lomo L, Gulbahce HE. Male Invasive Lobular Breast Cancer: Clinicopathologic Features Including Recurrence Score Results From a Population-Based Database. Archives of Pathology & Laboratory Medicine. Archives of Pathology and Laboratory Medicine; 2024; 148:263-264 10.5858/arpa.2023-0364-le
Experiences and perceptions of men following breast cancer diagnosis: a mixed method systematic review Cite
Abboah-Offei M, Bayuo J, Salifu Y, Afolabi O, Akudjedu TN. Experiences and perceptions of men following breast cancer diagnosis: a mixed method systematic review. BMC Cancer. Springer Science and Business Media LLC; 2024; 24 10.1186/s12885-024-11911-9
Time Trends in Male Breast Cancer Incidence, Mortality, and Survival in Austria (1983–2017) Cite
Ilic L, Simon J, Hackl M, Haidinger G. Time Trends in Male Breast Cancer Incidence, Mortality, and Survival in Austria (1983–2017). Clinical Epidemiology. Informa UK Limited; 2024; Volume 16:57-69 10.2147/clep.s428824
Aggressive Male Breast Cancer—Clinical and Therapeutic Aspects Correlated with the Histopathological Examination: A Case Report and Literature Review Cite
Petrescu A, Pirici N, Ruxanda A, Vasile L, Pîrșcoveanu M, Paitici Ș, et al. Aggressive Male Breast Cancer—Clinical and Therapeutic Aspects Correlated with the Histopathological Examination: A Case Report and Literature Review. Medicina. MDPI AG; 2023; 59:2167 10.3390/medicina59122167
Moderate Intensity Exercise Reduces Side Effects of Cancer Therapy and Maintains Cardiorespiratory Fitness in Male Breast Cancer Patients: Findings from the BRECA Male Crossover Study Cite
Schultz EB, Zubac D, Bloch W, Baurecht H, Rickert J, Baumann FT. Moderate Intensity Exercise Reduces Side Effects of Cancer Therapy and Maintains Cardiorespiratory Fitness in Male Breast Cancer Patients: Findings from the BRECA Male Crossover Study. Breast Care. S. Karger AG; 2023; 18:485-494 10.1159/000534090
Nationwide Analysis of Locoregional Management for Ductal Carcinoma In Situ in Males: An NCDB Analysis of the Surgical Approach to DCIS in Males Cite
Carter MM, Whitrock JN, Pratt CG, Shaughnessy EA, Meier TM, Barrord MF, et al. Nationwide Analysis of Locoregional Management for Ductal Carcinoma In Situ in Males: An NCDB Analysis of the Surgical Approach to DCIS in Males. Annals of Surgical Oncology. Springer Science and Business Media LLC; 2023; 10.1245/s10434-023-14579-w
Clinical, Pathological, and Prognostic Features of Male Breast Cancer: A Multicenter Study Cite
Accomasso F, Actis S, Minella C, Rosso R, Granaglia C, Ponzone R, et al. Clinical, Pathological, and Prognostic Features of Male Breast Cancer: A Multicenter Study. Current Oncology. MDPI AG; 2023; 30:9860-9871 10.3390/curroncol30110716
Prediction models for hormone receptor status in female breast cancer do not extend to males: further evidence of sex-based disparity in breast cancer Cite
Chatterji S, Niehues JM, van Treeck M, Loeffler CML, Saldanha OL, Veldhuizen GP, et al. Prediction models for hormone receptor status in female breast cancer do not extend to males: further evidence of sex-based disparity in breast cancer. npj Breast Cancer. Springer Science and Business Media LLC; 2023; 9 10.1038/s41523-023-00599-y
Is There a Survival Difference Between Male and Female Breast Cancer Subtypes According to the Prognostic Staging System? A Population-Based Cohort Study Cite
Sanli AN, Tekcan Sanli DE, Altundag MK, Aydogan F. Is There a Survival Difference Between Male and Female Breast Cancer Subtypes According to the Prognostic Staging System? A Population-Based Cohort Study. The American Surgeon™. SAGE Publications; 2023; 10.1177/00031348231212588
Outcomes of male patients with HR+/HER2– advanced breast cancer receiving palbociclib in the real-world POLARIS study Cite
Blum JL, DiCristo C, Gordon D, Karuturi MS, Oubre D, Jepsen E, et al. Outcomes of male patients with HR+/HER2– advanced breast cancer receiving palbociclib in the real-world POLARIS study. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2023; 10.1007/s10549-023-07145-1
Neoadjuvant treatment for male breast cancer Cite
Fentiman IS. Neoadjuvant treatment for male breast cancer. Translational Cancer Research. AME Publishing Company; 2023; 12:1669-1671 10.21037/tcr-23-592
Management of Male Patients With Occult Breast Cancer: Analysis of the National Cancer Database Cite
Wong WG, Perez Holguin RA, Kanwar R, Dodge D, Shen C. Management of Male Patients With Occult Breast Cancer: Analysis of the National Cancer Database. Journal of Surgical Research. Elsevier BV; 2024; 293:685-692 10.1016/j.jss.2023.08.053
Treatment utilization and effectiveness of neoadjuvant chemotherapy comparing men and women diagnosed with breast cancer: a Swedish retrospective cohort study Cite
Schiza A, Fredriksson I, Sund M, Valachis A. Treatment utilization and effectiveness of neoadjuvant chemotherapy comparing men and women diagnosed with breast cancer: a Swedish retrospective cohort study. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2023; 10.1007/s10549-023-07129-1
Post Mastectomy Radiation Therapy Impact on Clinical Outcomes of Male Breast Cancer: A Meta-Analysis of Comparative Studies Cite
Haddad P, Zaheer U. Post Mastectomy Radiation Therapy Impact on Clinical Outcomes of Male Breast Cancer: A Meta-Analysis of Comparative Studies. International Journal of Radiation Oncology*Biology*Physics. Elsevier BV; 2023; 117:e176 10.1016/j.ijrobp.2023.06.1023
Analysis of the distinct features of metastasis male breast cancer and its effect on overall survival based on the SEER database compared with female breast cancer Cite
Li H, Zhang Y, Teh M, Limaye S, Cavalcante FP, Shen J. Analysis of the distinct features of metastasis male breast cancer and its effect on overall survival based on the SEER database compared with female breast cancer. Translational Cancer Research. AME Publishing Company; 2023; 12:2371-2378 10.21037/tcr-23-1175
Breast Reconstruction in Male Breast Cancer Patients: An analysis of trends using the NSQIP database Cite
Towfighi P, Haffner ZK, Sayyed AA, Deldar R, Sogunro O, Hawa AAAE, et al. Breast Reconstruction in Male Breast Cancer Patients: An analysis of trends using the NSQIP database. European Journal of Plastic Surgery. Springer Science and Business Media LLC; 2023; 10.1007/s00238-023-02091-z
Treatments for breast cancer in men: late effects and impact on quality of life Cite
Avila J, Herrick B, Attai DJ, Leone JP. Treatments for breast cancer in men: late effects and impact on quality of life. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2023; 10.1007/s10549-023-07027-6
Secretory breast cancer in a boy: A case report with genetic analysis using next-generation sequencing and literature review Cite
Deng L, Li Y, Zhong J. Secretory breast cancer in a boy: A case report with genetic analysis using next-generation sequencing and literature review. Medicine. Ovid Technologies (Wolters Kluwer Health); 2023; 102:e34192 10.1097/md.0000000000034192
Y chromosome loss in cancer drives growth by evasion of adaptive immunity Cite
Abdel-Hafiz HA, Schafer JM, Chen X, Xiao T, Gauntner TD, Li Z, et al. Y chromosome loss in cancer drives growth by evasion of adaptive immunity. Nature. Springer Science and Business Media LLC; 2023; 10.1038/s41586-023-06234-x
Quality of Life in Male Breast Cancer: Prospective Study of the International Male Breast Cancer Program (EORTC10085/TBCRC029/BIG2-07/NABCG) Cite
Schröder CP, van Leeuwen-Stok E, Cardoso F, Linderholm B, Poncet C, Wolff AC, et al. Quality of Life in Male Breast Cancer: Prospective Study of the International Male Breast Cancer Program (EORTC10085/TBCRC029/BIG2-07/NABCG). The Oncologist. Oxford University Press (OUP); 2023; 10.1093/oncolo/oyad152
Men’s stories of living with breast cancer: A systematic review, metasynthesis, and proposed framework. Cite
Rudd É, Fortin J, Brunet A. Men’s stories of living with breast cancer: A systematic review, metasynthesis, and proposed framework.. Psychology of Men & Masculinities. American Psychological Association (APA); 2023; 10.1037/men0000438
Breast cancer: the first comparative evaluation of oncobiome composition between males and females Cite
Niccolai E, Baldi S, Nannini G, Gensini F, Papi L, Vezzosi V, et al. Breast cancer: the first comparative evaluation of oncobiome composition between males and females. Biology of Sex Differences. Springer Science and Business Media LLC; 2023; 14 10.1186/s13293-023-00523-w
An analysis of National Cancer Data Base: Male breast cancer and overall survival. Cite
Albagoush S, Masih D, Wu X, Swedek M, Randhawa SE, Silberstein PT. An analysis of National Cancer Data Base: Male breast cancer and overall survival.. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2023; 41:e12513-e12513 10.1200/jco.2023.41.16_suppl.e12513
Deep learning models predicting hormone receptor status in breast cancer trained on females do not generalize to males: further evidence of sex-based disparity in breast cancer Cite
Chatterji S, Niehues J, Treeck Mv, Loeffler C, Saldanha O, Veldhuizen G, et al. Deep learning models predicting hormone receptor status in breast cancer trained on females do not generalize to males: further evidence of sex-based disparity in breast cancer. Research Square Platform LLC; 2023; 10.21203/rs.3.rs-2996566/v1
Male breast cancer risk associated with pathogenic variants in genes other than BRCA1/2: an Italian case-control study Cite
Bucalo A, Conti G, Valentini V, Capalbo C, Bruselles A, Tartaglia M, et al. Male breast cancer risk associated with pathogenic variants in genes other than BRCA1/2: an Italian case-control study. European Journal of Cancer. Elsevier BV; 2023; 188:183-191 10.1016/j.ejca.2023.04.022
Axillary Lymph Node Dissection is Associated with Improved Survival Among Men with Invasive Breast Cancer and Sentinel Node Metastasis Cite
Chung SH, de Geus SWL, Shewmaker G, Romatoski KS, Drake FT, Ko NY, et al. Axillary Lymph Node Dissection is Associated with Improved Survival Among Men with Invasive Breast Cancer and Sentinel Node Metastasis. Annals of Surgical Oncology. Springer Science and Business Media LLC; 2023; 10.1245/s10434-023-13475-7
87P Breaking down the divide: An analysis of male breast cancer demographics and survival by race in the United States Cite
Yadukumar L, Gogtay M, Singh A, Sharma N. 87P Breaking down the divide: An analysis of male breast cancer demographics and survival by race in the United States. ESMO Open. Elsevier BV; 2023; 8:101310 10.1016/j.esmoop.2023.101310
181P Male breast cancer (MBC): Familial history (FH), clinicopathological (CP) characteristics, oncogenetic (OG) testing and outcome in a cohort of 98 patients (pts) Cite
Chretien S, Aymes E, Barthoulot M, Deley ML, Boulaire M, Oca F, et al. 181P Male breast cancer (MBC): Familial history (FH), clinicopathological (CP) characteristics, oncogenetic (OG) testing and outcome in a cohort of 98 patients (pts). ESMO Open. Elsevier BV; 2023; 8:101458 10.1016/j.esmoop.2023.101458
Survival in male breast cancer over the past 3 decades Cite
Leone JP, Freedman RA, Leone J, Tolaney SM, Vallejo CT, Leone BA, et al. Survival in male breast cancer over the past 3 decades. JNCI: Journal of the National Cancer Institute. Oxford University Press (OUP); 2022; 115:421-428 10.1093/jnci/djac241
Molecular subtypes predict the prognosis of male breast cancer: a retrospective cohort study Cite
Wang M, Liu D, Zhang Z, Dai X, Chen G, Zhu L. Molecular subtypes predict the prognosis of male breast cancer: a retrospective cohort study. Translational Breast Cancer Research. AME Publishing Company; 2023; 4:4-4 10.21037/tbcr-22-24
Outcomes of Rural Men with Breast Cancer: A Multicenter Population Based Retrospective Cohort Study Cite
Fisher LAB, Ahmed O, Chalchal HI, Deobald R, El-Gayed A, Graham P, et al. Outcomes of Rural Men with Breast Cancer: A Multicenter Population Based Retrospective Cohort Study. Cancers. MDPI AG; 2023; 15:1995 10.3390/cancers15071995
Molecular characteristics of Asian male BRCA-related cancers Cite
Kwong A, Ho CYS, Shin VY, Ng ATL, Chan TL, Ma ESK. Molecular characteristics of Asian male BRCA-related cancers. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2023; 198:391-400 10.1007/s10549-022-06651-y
Abstract PD6-11: PD6-11 Evaluation of the Sensitivity to Endocrine Therapy Index (SET2,3) in Early Male Breast Cancer: Results from an analysis in the EORTC 10085/TBCRC/BIG/NCTN International Male Breast Cancer Program Cite
Zakon DB, Poncet C, Cardoso F, Anouk N, Valero V, Aebi S, et al. Abstract PD6-11: PD6-11 Evaluation of the Sensitivity to Endocrine Therapy Index (SET2,3) in Early Male Breast Cancer: Results from an analysis in the EORTC 10085/TBCRC/BIG/NCTN International Male Breast Cancer Program. Cancer Research. American Association for Cancer Research (AACR); 2023; 83:PD6-11-PD6-11 10.1158/1538-7445.sabcs22-pd6-11
Abstract PD6-10: PD6-10 The impact of post mastectomy radiation therapy on clinical outcomes of male breast cancer: A meta-analysis of comparative studies Cite
Haddad PA, Zaheer U. Abstract PD6-10: PD6-10 The impact of post mastectomy radiation therapy on clinical outcomes of male breast cancer: A meta-analysis of comparative studies. Cancer Research. American Association for Cancer Research (AACR); 2023; 83:PD6-10-PD6-10 10.1158/1538-7445.sabcs22-pd6-10
Abstract PD6-08: PD6-08 Mortality risks over 20 years in men with stage I-III hormone receptor-positive breast cancer Cite
Leone J, Hassett MJ, Freedman R, Tolaney S, Graham N, Tayob N, et al. Abstract PD6-08: PD6-08 Mortality risks over 20 years in men with stage I-III hormone receptor-positive breast cancer. Cancer Research. American Association for Cancer Research (AACR); 2023; 83:PD6-08-PD6-08 10.1158/1538-7445.sabcs22-pd6-08
Abstract P4-03-37: The characteristics of male breast cancer by molecular subtypes: a population-based study Cite
Wang M, Liu D, Zhu L. Abstract P4-03-37: The characteristics of male breast cancer by molecular subtypes: a population-based study. Cancer Research. American Association for Cancer Research (AACR); 2023; 83:P4-03-37-P4-03-37 10.1158/1538-7445.sabcs22-p4-03-37
The association of race/ethnicity in male breast cancer survival within similar comorbidity cohorts Cite
Parise CA, Caggiano V. The association of race/ethnicity in male breast cancer survival within similar comorbidity cohorts. Cancer. Wiley; 2023; 129:750-763 10.1002/cncr.34592
Clinicopathological features, genetic alterations, and BRCA1 promoter methylation in Japanese male patients with breast cancer Cite
Shimomura A, Yoshida M, Kubo T, Yamashita S, Noguchi E, Nagayama A, et al. Clinicopathological features, genetic alterations, and BRCA1 promoter methylation in Japanese male patients with breast cancer. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2022; 10.1007/s10549-022-06822-x
Characteristics, treatment and outcomes of HER2 positive male breast cancer Cite
Esposito A, Ablah E, Okut H, Tenofsky PL. Characteristics, treatment and outcomes of HER2 positive male breast cancer. The American Journal of Surgery. Elsevier BV; 2022; 10.1016/j.amjsurg.2022.12.009
ACR Appropriateness Criteria® Evaluation of Nipple Discharge: 2022 Update Cite
Sanford MF, Slanetz PJ, Lewin AA, Baskies AM, Bozzuto L, Branton SA, et al. ACR Appropriateness Criteria® Evaluation of Nipple Discharge: 2022 Update. Journal of the American College of Radiology. Elsevier BV; 2022; 19:S304-S318 10.1016/j.jacr.2022.09.020
Genetic Predisposition to Male Breast Cancer: A Case Series Cite
APESSOS A, AGIANNITOPOULOS K, PEPE G, TSAOUSIS GN, PITTA P, BILI C, et al. Genetic Predisposition to Male Breast Cancer: A Case Series. Anticancer Research. Anticancer Research USA Inc.; 2022; 42:5795-5801 10.21873/anticanres.16086
Management of Gynecomastia and Male Benign Diseases Cite
Karamchandani MM, De La Cruz Ku G, Sokol BL, Chatterjee A, Homsy C. Management of Gynecomastia and Male Benign Diseases. Surgical Clinics of North America. Elsevier BV; 2022; 102:989-1005 10.1016/j.suc.2022.06.003
Ductal carcinoma in situ of the male breast: clinical radiological features and management in a cancer referral center Cite
Nicosia L, Lissidini G, Sargenti M, Bozzini AC, Farante G, Vila J, et al. Ductal carcinoma in situ of the male breast: clinical radiological features and management in a cancer referral center. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2022; 196:371-377 10.1007/s10549-022-06689-y
Prognostic Predictors of Mortality in Male Breast Cancer: Outcomes in an Urban Population Cite
Sogunro OA, Maini M, Deldar R, Maini AS, Greige N, Greenwalt I, et al. Prognostic Predictors of Mortality in Male Breast Cancer: Outcomes in an Urban Population. Journal of Surgical Research. Elsevier BV; 2023; 281:192-199 10.1016/j.jss.2022.08.035
Male breast cancer: a 20-year multicenter experience Cite
Zheng G, Wang H, Liu F, Leone JP. Male breast cancer: a 20-year multicenter experience. Breast Cancer Management. Future Medicine Ltd; 2022; 11 10.2217/bmt-2022-0004
Burden, trends, and risk factors for breast cancer in China from 1990 to 2019 and its predictions until 2034: an up-to-date overview and comparison with those in Japan and South Korea Cite
Liu N, Yang D, Wu Y, Xue W, Li D, Zhang J, et al. Burden, trends, and risk factors for breast cancer in China from 1990 to 2019 and its predictions until 2034: an up-to-date overview and comparison with those in Japan and South Korea. BMC Cancer. Springer Science and Business Media LLC; 2022; 22 10.1186/s12885-022-09923-4
Metformin and testosterone replacement therapy inversely associated with hormone‐associated cancers (prostate, colorectal and male breast cancers) among older White and Black men Cite
Lopez DS, Malagaris I, Polychronopoulou E, Tsilidis KK, Milani SA, Kristen Peek M, et al. Metformin and testosterone replacement therapy inversely associated with hormone‐associated cancers (prostate, colorectal and male breast cancers) among older White and Black men. Clinical Endocrinology. Wiley; 2022; 10.1111/cen.14803
Risk of Developing a Second Primary Cancer in Male Breast Cancer Survivors: A Systematic Review and Meta-Analysis Cite
Allen I, Hassan H, Sofianopoulou E, Eccles DM, Turnbull C, Tischkowitz M, et al. Risk of Developing a Second Primary Cancer in Male Breast Cancer Survivors: A Systematic Review and Meta-Analysis. Apollo - University of Cambridge Repository; 2022; 10.17863/CAM.87045
Lifetime exposure to welding fume and risk of some rare cancers Cite
Kendzia B, Kaerlev L, Ahrens W, Merletti F, Eriksson M, Guénel P, et al. Lifetime exposure to welding fume and risk of some rare cancers. American Journal of Epidemiology. Oxford University Press (OUP); 2022; 10.1093/aje/kwac123
The role of postoperative radiation therapy in stage I–III male breast cancer: A population-based study from the Surveillance, Epidemiology, and End Results database Cite
Wu P, He D, Zhu S, Chang H, Wang Q, Shao Q, et al. The role of postoperative radiation therapy in stage I–III male breast cancer: A population-based study from the Surveillance, Epidemiology, and End Results database. The Breast. Elsevier BV; 2022; 10.1016/j.breast.2022.06.004
Impacts of subtypes on clinical feature and outcome of male breast cancer. Cite
Lee J, Lee KS, Sohn J, Lee K, Jung KH, Byun JH, et al. Impacts of subtypes on clinical feature and outcome of male breast cancer.. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2022; 40:e12528-e12528 10.1200/jco.2022.40.16_suppl.e12528
Local aromatase excess with recruitment of unusual promoters of CYP19A1 gene in prepubertal patients with gynecomastia Cite
Deberles E, Durand I, Mittre H, Reznik Y, Morera J. Local aromatase excess with recruitment of unusual promoters of CYP19A1 gene in prepubertal patients with gynecomastia. Journal of Pediatric Endocrinology and Metabolism. Walter de Gruyter GmbH; 2022; 0 10.1515/jpem-2021-0757
A comparative analysis of males and females with breast cancer undergoing mastectomy using the American College of Surgeon’s National Surgical Quality Improvement Project (NSQIP) Cite
Towfighi P, Deldar R, Haffner ZK, Aminpour N, Sogunro O, Abu El Hawa AA, et al. A comparative analysis of males and females with breast cancer undergoing mastectomy using the American College of Surgeon’s National Surgical Quality Improvement Project (NSQIP). Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2022; 10.1007/s10549-022-06628-x
Infertility and risk of breast cancer in men: a national case–control study in England and Wales Cite
Swerdlow AJ, Bruce C, Cooke R, Coulson P, Jones ME. Infertility and risk of breast cancer in men: a national case–control study in England and Wales. Breast Cancer Research. Springer Science and Business Media LLC; 2022; 24 10.1186/s13058-022-01517-z
Relevance of the 21-gene expression assay in male breast cancer: A systematic review and meta-analysis Cite
Davey MG, Davey CM, Bouz L, Kerin E, McFeetors C, Lowery AJ, et al. Relevance of the 21-gene expression assay in male breast cancer: A systematic review and meta-analysis. The Breast. Elsevier BV; 2022; 64:41-46 10.1016/j.breast.2022.04.009
Abstract P3-12-31: A 10 year retrospective study of male breast cancer patients within central Scotland Cite
Morris RE, Pitsinis V. Abstract P3-12-31: A 10 year retrospective study of male breast cancer patients within central Scotland. Cancer Research. American Association for Cancer Research (AACR); 2022; 82:P3-12-31-P3-12-31 10.1158/1538-7445.sabcs21-p3-12-31
Postmastectomy Reconstruction in Male Breast Cancer Cite
Deldar R, Sayyed AA, Towfighi P, Aminpour N, Sogunro O, Son JD, et al. Postmastectomy Reconstruction in Male Breast Cancer. The Breast Journal. Hindawi Limited; 2022; 2022:1-7 10.1155/2022/5482261
The Frequency and Prognostic Significance of ABO/Rh Blood Groups in Male Breast Cancer Patients: A Multi-center Study Cite
Dogan I, Ayhan M, Gurbuz M, Kucukarda A, Aydin E, Urun Y, et al. The Frequency and Prognostic Significance of ABO/Rh Blood Groups in Male Breast Cancer Patients: A Multi-center Study. Research Square Platform LLC; 2022; 10.21203/rs.3.rs-1409616/v1
Incidental Pathologic Findings in Young Men with Gynecomastia Cite
Maroney JC, Dannheim K, Hollowell ML, Labow BI, Rogers-Vizena CR. Incidental Pathologic Findings in Young Men with Gynecomastia. Plastic & Reconstructive Surgery. Ovid Technologies (Wolters Kluwer Health); 2022; 149:608-613 10.1097/prs.0000000000008815
The Prevalence and Death Risk of Male Breast Cancer: A Study Based on the Surveillance, Epidemiology, and End Results Database Cite
Cui X. The Prevalence and Death Risk of Male Breast Cancer: A Study Based on the Surveillance, Epidemiology, and End Results Database. American Journal of Men's Health. SAGE Publications; 2022; 16:155798832210748 10.1177/15579883221074818
Breast and Prostate Cancer Risks for Male BRCA1 and BRCA2 Pathogenic Variant Carriers Using Polygenic Risk Scores Cite
Barnes DR, Silvestri V, Leslie G, McGuffog L, Dennis J, Yang X, et al. Breast and Prostate Cancer Risks for Male BRCA1 and BRCA2 Pathogenic Variant Carriers Using Polygenic Risk Scores. JNCI: Journal of the National Cancer Institute. Oxford University Press (OUP); 2021; 114:109-122 10.1093/jnci/djab147
Risk of breast cancer in men in relation to weight change: a national case‐control study in England and Wales Cite
Swerdlow AJ, Bruce C, Cooke R, Coulson P, Schoemaker MJ, Jones ME. Risk of breast cancer in men in relation to weight change: a national case‐control study in England and Wales. International Journal of Cancer. Wiley; 2022; 10.1002/ijc.33938
Clinicopathologic characteristics and prognosis for male breast cancer compared to female breast cancer Cite
Yao N, Shi W, Liu T, Siyin ST, Wang W, Duan N, et al. Clinicopathologic characteristics and prognosis for male breast cancer compared to female breast cancer. Scientific Reports. Springer Science and Business Media LLC; 2022; 12 10.1038/s41598-021-04342-0
Prognostic Factors in Male Breast Cancer: A Retrospective Nationwide Study in South Korea by the Study of SMARTSHIP Group Cite
Park S, Hur H, Lee JS, Yoon J, Hur SM, Chung IY, et al. Prognostic Factors in Male Breast Cancer: A Retrospective Nationwide Study in South Korea by the Study of SMARTSHIP Group. Journal of Breast Cancer. Korean Breast Cancer Society; 2021; 24:561 10.4048/jbc.2021.24.e54
Tree nut consumption is associated with a lower risk of hyperestrogenism in men Cite
Wang Y, Fang Y. Tree nut consumption is associated with a lower risk of hyperestrogenism in men. Nutrition Research. Elsevier BV; 2021; 10.1016/j.nutres.2021.12.001
Characteristics of metastasis and survival between male and female breast cancer with different molecular subtypes: A population‐based observational study Cite
Fang W, Huang Y, Han X, Peng J, Zheng M. Characteristics of metastasis and survival between male and female breast cancer with different molecular subtypes: A population‐based observational study. Cancer Medicine. Wiley; 2021; 10.1002/cam4.4469
Excess risk of male breast cancer in the Norwegian Offshore Petroleum Workers (NOPW) cohort: a possible link to extreme night shift work? Cite
Liu F, Veierød MB, Kjærheim K, Robsahm TE, Ghiasvand R, Babigumira R, et al. Excess risk of male breast cancer in the Norwegian Offshore Petroleum Workers (NOPW) cohort: a possible link to extreme night shift work?. Breast Cancer Research. Springer Science and Business Media LLC; 2021; 23 10.1186/s13058-021-01485-w
A practical guide to endocrine therapy in the management of estrogen receptor-positive male breast cancer Cite
Yadav S, Giridhar KV, Leone JP, Leon-Ferre RA, Ruddy KJ. A practical guide to endocrine therapy in the management of estrogen receptor-positive male breast cancer. Breast Cancer Management. Future Medicine Ltd; 2021; 10:BMT59 10.2217/bmt-2021-0001
Care of men with cancer-predisposing BRCA variants Cite
Horton R, Pharoah P, Hayward J, Lucassen A. Care of men with cancer-predisposing BRCA variants. BMJ. BMJ; 2021;:n2376 10.1136/bmj.n2376
Penetrance of male breast cancer susceptibility genes: a systematic review Cite
Chamseddine RS, Wang C, Yin K, Wang J, Singh P, Zhou J, et al. Penetrance of male breast cancer susceptibility genes: a systematic review. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2021; 10.1007/s10549-021-06413-2
Trend and survival benefit of contralateral prophylactic mastectomy among men with stage I–III unilateral breast cancer in the USA, 1998–2016 Cite
Yang Y, Pan L, Shao Z. Trend and survival benefit of contralateral prophylactic mastectomy among men with stage I–III unilateral breast cancer in the USA, 1998–2016. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2021; 10.1007/s10549-021-06397-z
Treatment of male breast cancer: meta-analysis of real-world evidence Cite
Lin AP, Huang T-, Tam K-. Treatment of male breast cancer: meta-analysis of real-world evidence. British Journal of Surgery. Oxford University Press (OUP); 2021; 10.1093/bjs/znab279
Obesity and Breast Cancer Risk in Men: A National Case-Control Study in England and Wales Cite
Swerdlow AJ, Bruce C, Cooke R, Coulson P, Griffin J, Butlin A, et al. Obesity and Breast Cancer Risk in Men: A National Case-Control Study in England and Wales. JNCI Cancer Spectrum. Oxford University Press (OUP); 2021; 10.1093/jncics/pkab078
A Systematic Comparison of Overall Survival Between Men and Women With Triple Negative Breast Cancer Cite
Yadav SK, Silwal S, Yadav S, Krishnamoorthy G, Chisti MM. A Systematic Comparison of Overall Survival Between Men and Women With Triple Negative Breast Cancer. Clinical Breast Cancer. Elsevier BV; 2021; 10.1016/j.clbc.2021.07.001
Common Considerations in Male Breast Cancer Survivors Cite
Yadav S, Giridhar KV, Ruddy KJ, Leon-Ferre RA. Common Considerations in Male Breast Cancer Survivors. Common Issues in Breast Cancer Survivors. Springer International Publishing; 2021;:319-328 10.1007/978-3-030-75377-1_21
BRCA Germline Mutations in Prostate Cancer: The Future Is Tailored Cite
Crocetto F, Barone B, Caputo VF, Fontana M, de Cobelli O, Ferro M. BRCA Germline Mutations in Prostate Cancer: The Future Is Tailored. Diagnostics. MDPI AG; 2021; 11:908 10.3390/diagnostics11050908
Poor prognosis of male triple-positive breast Cancer patients: a propensity score matched SEER analysis and molecular portraits Cite
Wang B, Wang H, Zhao A, Zhang M, Yang J. Poor prognosis of male triple-positive breast Cancer patients: a propensity score matched SEER analysis and molecular portraits. BMC Cancer. Springer Science and Business Media LLC; 2021; 21 10.1186/s12885-021-08267-9
Male and female breast cancer: the two faces of the same genetic susceptibility coin Cite
Silva SN, Gomes BC, André S, Félix A, Rodrigues AS, Rueff J. Male and female breast cancer: the two faces of the same genetic susceptibility coin. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2021; 10.1007/s10549-021-06159-x
Male Triple-Negative Breast Cancer Cite
Qavi Q, Alkistawi F, Kumar S, Ahmed R, Saad Abdalla Al-Zawi A. Male Triple-Negative Breast Cancer. Cureus. Cureus, Inc.; 2021; 10.7759/cureus.14542
Management and outcomes of men diagnosed with primary breast cancer Cite
Johnson AE, Coopey SB, Spring LM, Horick NK, Leone JP, Lin NU, et al. Management and outcomes of men diagnosed with primary breast cancer. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2021; 10.1007/s10549-021-06174-y
Heredity and Male Breast Cancer: A Series of 72 Men with Breast Cancer Cite
Rodríguez-Fernández V, Cameselle-Cortizo L, García-Mallo A, Ortiz Elena M, Castro-Parga GJD, Figueiredo-Alonso E, et al. Heredity and Male Breast Cancer: A Series of 72 Men with Breast Cancer. International Journal of Medical Science and Health Research. International Journal of Medical Science and Health Research; 2021; 05:155-166 10.51505/ijmshr.2021.5213
Tumor subtypes and survival in male breast cancer Cite
Leone J, Freedman RA, Lin NU, Tolaney SM, Vallejo CT, Leone BA, et al. Tumor subtypes and survival in male breast cancer. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2021; 10.1007/s10549-021-06182-y
The Use of Adjuvant Radiation Therapy in Male Breast Cancer and Its Impact on Outcomes. Cite
Bakalov V, Jayakrishnan TT, Abel S, Hilton C, Rusia B, Wegner RE. The Use of Adjuvant Radiation Therapy in Male Breast Cancer and Its Impact on Outcomes.. Cancer Treatment and Research Communications. Elsevier BV; 2021;:100359 10.1016/j.ctarc.2021.100359
Gender Disparity in Breast Cancer: A Veteran Population-Based Comparison Cite
Aggarwal A, Adepoju B, Yacur M, Maron D, Sharma MC. Gender Disparity in Breast Cancer: A Veteran Population-Based Comparison. Clinical Breast Cancer. Elsevier BV; 2021; 10.1016/j.clbc.2021.01.013
Abstract PS14-25: Outcomes of metastatic male breast cancer Cite
Dogan I, Khanmammadov N, Aydıner A, Saip P. Abstract PS14-25: Outcomes of metastatic male breast cancer. Poster Session Abstracts. American Association for Cancer Research; 2021; 10.1158/1538-7445.sabcs20-ps14-25
Efficacy of Endocrine Therapy for the Treatment of Breast Cancer in Men Cite
Reinisch M, Seiler S, Hauzenberger T, Kamischke A, Schmatloch S, Strittmatter H, et al. Efficacy of Endocrine Therapy for the Treatment of Breast Cancer in Men. JAMA Oncology. American Medical Association (AMA); 2021; 10.1001/jamaoncol.2020.7442
Management and outcome of male metastatic breast cancer in the national multicenter observational research program Epidemiological Strategy and Medical Economics (ESME) Cite
Sirieix J, Fraisse J, Mathoulin-Pelissier S, Leheurteur M, Vanlemmens L, Jouannaud C, et al. Management and outcome of male metastatic breast cancer in the national multicenter observational research program Epidemiological Strategy and Medical Economics (ESME). Therapeutic Advances in Medical Oncology. SAGE Publications; 2020; 12:175883592098054 10.1177/1758835920980548
Male Breast Cancer: 13-Year Single Institution Experience Cite
Srour MK, Amersi F, Mirocha J, Giuliano AE, Chung A. Male Breast Cancer: 13-Year Single Institution Experience. The American Surgeon. SAGE Publications; 2020; 86:1345-1350 10.1177/0003134820964444
The Role of Radiation Therapy in Addition to Lumpectomy and Hormone Therapy in Men 70 Years of Age and Older with Early Breast Cancer: A NCDB Analysis Cite
Bateni SB, Perry LM, Zhao X, Arora M, Daly ME, Stewart SL, et al. The Role of Radiation Therapy in Addition to Lumpectomy and Hormone Therapy in Men 70 Years of Age and Older with Early Breast Cancer: A NCDB Analysis. Annals of Surgical Oncology. Springer Science and Business Media LLC; 2020; 10.1245/s10434-020-09242-7
Breast Cancer Survival Among Males by Race, Ethnicity, Age, Geographic Region, and Stage — United States, 2007–2016 Cite
Ellington TD, Henley SJ, Wilson RJ, Miller JW. Breast Cancer Survival Among Males by Race, Ethnicity, Age, Geographic Region, and Stage — United States, 2007–2016. MMWR. Morbidity and Mortality Weekly Report. Centers for Disease Control MMWR Office; 2020; 69:1481-1484 10.15585/mmwr.mm6941a2
The role of adjuvant chemotherapy in stage I–III male breast cancer: a SEER-based analysis Cite
Li W, Gao H, Ji F, Zhu T, Cheng M, Yang M, et al. The role of adjuvant chemotherapy in stage I–III male breast cancer: a SEER-based analysis. Therapeutic Advances in Medical Oncology. SAGE Publications; 2020; 12:175883592095835 10.1177/1758835920958358
Family history of breast cancer in men with non-BRCA male breast cancer: implications for cancer risk counseling Cite
Calip GS, Kidd J, Bernhisel R, Cox HC, Saam J, Rauscher GH, et al. Family history of breast cancer in men with non-BRCA male breast cancer: implications for cancer risk counseling. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2020; 10.1007/s10549-020-05922-w
Management of Male Breast Cancer: ASCO Guideline Summary Cite
Hassett MJ, Somerfield MR, Giordano SH. Management of Male Breast Cancer: ASCO Guideline Summary. JCO Oncology Practice. American Society of Clinical Oncology (ASCO); 2020; 16:e839-e843 10.1200/jop.19.00792
The effect of chemotherapy on survival in patients with nonmetastatic male breast cancer: A population‐based observational study Cite
Pan H, Zhang K, Wang M, Ling L, Wang S, Zhou W. The effect of chemotherapy on survival in patients with nonmetastatic male breast cancer: A population‐based observational study. Cancer. Wiley; 2020; 126:3830-3836 10.1002/cncr.32829
Safety, efficacy, and tolerability of systemic therapies in male breast cancer: are there sex-specific differences? Cite
Yadav S, Giridhar KV, Taraba J, Leon-Ferre R, Ruddy KJ. Safety, efficacy, and tolerability of systemic therapies in male breast cancer: are there sex-specific differences?. Expert Opinion on Drug Safety. Informa UK Limited; 2020; 19:923-926 10.1080/14740338.2020.1796964
Surgery for Men with Breast Cancer: Do the Same Data Still Apply? Cite
Plichta JK, Ren Y, Marks CE, Thomas SM, Greenup RA, Rosenberger LH, et al. Surgery for Men with Breast Cancer: Do the Same Data Still Apply?. Annals of Surgical Oncology. Springer Science and Business Media LLC; 2020; 27:4720-4729 10.1245/s10434-020-08901-z
Breast Cancer in Men: Clinical and Pathological Analysis of 817 Cases Cite
Spreafico FS, Cardoso-Filho C, Cabello C, Sarian LO, Zeferino LC, Vale DB. Breast Cancer in Men: Clinical and Pathological Analysis of 817 Cases. American Journal of Men's Health. SAGE Publications; 2020; 14:155798832090810 10.1177/1557988320908109
Utility of Oncotype DX in Male Breast Cancer Patients and Impact on Chemotherapy Administration: A Comparative Study with Female Patients Cite
Williams AD, McGreevy CM, Tchou JC, De La Cruz LM. Utility of Oncotype DX in Male Breast Cancer Patients and Impact on Chemotherapy Administration: A Comparative Study with Female Patients. Annals of Surgical Oncology. Springer Science and Business Media LLC; 2020; 27:3605-3611 10.1245/s10434-020-08473-y
Male Breast Cancer: Surgical and Genetic Features and a Multidisciplinary Management Strategy Cite
Pellini F, Granuzzo E, Urbani S, Mirandola S, Caldana M, Lombardi D, et al. Male Breast Cancer: Surgical and Genetic Features and a Multidisciplinary Management Strategy. Breast Care. S. Karger AG; 2019; 15:14-21 10.1159/000501711
Male Breast Cancer: Results of the Application of Multigene Panel Testing to an Italian Cohort of Patients Cite
Tedaldi G, Tebaldi M, Zampiga V, Cangini I, Pirini F, Ferracci E, et al. Male Breast Cancer: Results of the Application of Multigene Panel Testing to an Italian Cohort of Patients. Diagnostics. MDPI AG; 2020; 10:269 10.3390/diagnostics10050269
Survival benefit of tamoxifen in male breast cancer: prospective cohort analysis Cite
Eggemann H, Brucker C, Schrauder M, Thill M, Flock F, Reinisch M, et al. Survival benefit of tamoxifen in male breast cancer: prospective cohort analysis. British Journal of Cancer. Springer Science and Business Media LLC; 2020; 123:33-37 10.1038/s41416-020-0857-z
Breast Conserving Surgery Compared With Mastectomy in Male Breast Cancer: A Brief Systematic Review Cite
Sauder CA, Bateni SB, Davidson AJ, Nishijima DK. Breast Conserving Surgery Compared With Mastectomy in Male Breast Cancer: A Brief Systematic Review. Clinical Breast Cancer. Elsevier BV; 2020; 20:e309-e314 10.1016/j.clbc.2019.12.004
Loss of Y-Chromosome during Male Breast Carcinogenesis Cite
Agahozo MC, Timmermans MAM, Sleddens HFBM, Foekens R, Trapman-Jansen AMAC, Schröder CP, et al. Loss of Y-Chromosome during Male Breast Carcinogenesis. Cancers. MDPI AG; 2020; 12:631 10.3390/cancers12030631
Epidemiology and biological characteristics of male breast cancer in Italy Cite
Mangone L, Ferrari F, Mancuso P, Carrozzi G, Michiara M, Falcini F, et al. Epidemiology and biological characteristics of male breast cancer in Italy. Breast Cancer. Springer Science and Business Media LLC; 2020; 27:724-731 10.1007/s12282-020-01068-1
Impact of Adjuvant Radiation Therapy in Patients With Male Breast Cancer: A Multicenter International Analysis Cite
Rolf D, Elsayad K, Meheissen MA, Elkerm Y, Opitz C, Radke I, et al. Impact of Adjuvant Radiation Therapy in Patients With Male Breast Cancer: A Multicenter International Analysis. Advances in Radiation Oncology. Elsevier BV; 2020; 5:345-349 10.1016/j.adro.2020.01.006
Abstract P4-17-07: Demographics and survival in male breast cancer: An updated analysis of SEER database Cite
Khoury J, Anusim N, Macari D, Jaiyesimi I. Abstract P4-17-07: Demographics and survival in male breast cancer: An updated analysis of SEER database. Poster Session Abstracts. American Association for Cancer Research; 2020; 10.1158/1538-7445.sabcs19-p4-17-07
Management of Male Breast Cancer: ASCO Guideline Cite
Hassett MJ, Somerfield MR, Baker ER, Cardoso F, Kansal KJ, Kwait DC, et al. Management of Male Breast Cancer: ASCO Guideline. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2020; 38:1849-1863 10.1200/jco.19.03120
Male breast cancer: a closer look at patient and tumor characteristics and factors that affect survival using the National Cancer Database Cite
Sarmiento S, McColl M, Musavi L, Gani F, Canner JK, Jacobs L, et al. Male breast cancer: a closer look at patient and tumor characteristics and factors that affect survival using the National Cancer Database. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2020; 180:471-479 10.1007/s10549-020-05556-y
Breast Cancer in Men: Oncology Cite
Incorvaia L, Castiglia M, Ottini L, Gori S, Russo A, Bazan V. Breast Cancer in Men: Oncology. Plastic and Cosmetic Surgery of the Male Breast. Springer International Publishing; 2020;:85-92 10.1007/978-3-030-25502-2_10
Male breast cancer: a neglected disease Cite
Fentiman IS. Male breast cancer: a neglected disease. Breast Cancer Management. Future Medicine Ltd; 2019; 8:BMT32 10.2217/bmt-2019-0020
Breast Conserving Surgery Compared With Mastectomy in Male Breast Cancer: A Brief Systematic Review Cite
Sauder CA, Bateni SB, Davidson AJ, Nishijima DK. Breast Conserving Surgery Compared With Mastectomy in Male Breast Cancer: A Brief Systematic Review. Clinical Breast Cancer. Elsevier BV; 2020; 20:e309-e314 10.1016/j.clbc.2019.12.004
Subtype-Specific Breast Cancer Incidence Rates in Black versus White Men in the United States Cite
Sung H, DeSantis C, Jemal A. Subtype-Specific Breast Cancer Incidence Rates in Black versus White Men in the United States. JNCI Cancer Spectrum. Oxford University Press (OUP); 2019; 4 10.1093/jncics/pkz091
Male Breast Cancer: Current Trends—a Tertiary Care Centre Experience Cite
Shah T, Shah N, Vijay DG, Patel B, Patel S. Male Breast Cancer: Current Trends—a Tertiary Care Centre Experience. Indian Journal of Surgical Oncology. Springer Science and Business Media LLC; 2019; 11:7-11 10.1007/s13193-019-01021-5
Metastasis pattern and prognosis of male breast cancer patients in US: a population-based study from SEER database Cite
Xie J, Ying Y, Xu B, Li Y, Zhang X, Li C. Metastasis pattern and prognosis of male breast cancer patients in US: a population-based study from SEER database. Therapeutic Advances in Medical Oncology. SAGE Publications; 2019; 11:175883591988900 10.1177/1758835919889003
Transitional experience of men with breast cancer from diagnosis to survivorship: An integrative review Cite
Younas A, Sundus A, Inayat S. Transitional experience of men with breast cancer from diagnosis to survivorship: An integrative review. European Journal of Oncology Nursing. Elsevier BV; 2019; 42:141-152 10.1016/j.ejon.2019.09.005
Sex Disparity Observed for Oncotype DX Breast Recurrence Score in Predicting Mortality Among Patients with Early Stage ER-Positive Breast Cancer Cite
Wang F, Reid S, Zheng W, Pal T, Meszoely I, Mayer IA, et al. Sex Disparity Observed for Oncotype DX Breast Recurrence Score in Predicting Mortality Among Patients with Early Stage ER-Positive Breast Cancer. Clinical Cancer Research. American Association for Cancer Research (AACR); 2019; 26:101-109 10.1158/1078-0432.ccr-19-2424
Overall Mortality After Diagnosis of Breast Cancer in Men vs Women Cite
Wang F, Shu X, Meszoely I, Pal T, Mayer IA, Yu Z, et al. Overall Mortality After Diagnosis of Breast Cancer in Men vs Women. JAMA Oncology. American Medical Association (AMA); 2019; 5:1589 10.1001/jamaoncol.2019.2803
Male breast cancer in the United States: Treatment patterns and prognostic factors in the 21st century Cite
Yadav S, Karam D, Bin Riaz I, Xie H, Durani U, Duma N, et al. Male breast cancer in the United States: Treatment patterns and prognostic factors in the 21st century. Cancer. Wiley; 2019; 126:26-36 10.1002/cncr.32472
Survival Disparities in Male Patients With Breast Cancer Cite
RESTREPO DJ, BOCZAR D, HUAYLLANI MT, SISTI A, MCLAUGHLIN SA, SPAULDING A, et al. Survival Disparities in Male Patients With Breast Cancer. Anticancer Research. Anticancer Research USA Inc.; 2019; 39:5669-5674 10.21873/anticanres.13764
Breast Cancer Screening in High-Risk Men: A 12-year Longitudinal Observational Study of Male Breast Imaging Utilization and Outcomes Cite
Gao Y, Goldberg JE, Young TK, Babb JS, Moy L, Heller SL. Breast Cancer Screening in High-Risk Men: A 12-year Longitudinal Observational Study of Male Breast Imaging Utilization and Outcomes. Radiology. Radiological Society of North America (RSNA); 2019; 293:282-291 10.1148/radiol.2019190971
Occupational exposures and male breast cancer: A nested case-control study in the Nordic countries Cite
Talibov M, Hansen J, Heikkinen S, Martinsen J, Sparen P, Tryggvadottir L, et al. Occupational exposures and male breast cancer: A nested case-control study in the Nordic countries. The Breast. Elsevier BV; 2019; 48:65-72 10.1016/j.breast.2019.09.004
Male Breast Cancer—an Indian Multicenter Series of 106 Cases Cite
Chhabra MK, Chintamani , Kadyaprath G, Srivastva A, Selvakumar V, Ranjan P, et al. Male Breast Cancer—an Indian Multicenter Series of 106 Cases. Indian Journal of Surgery. Springer Science and Business Media LLC; 2019; 10.1007/s12262-019-01953-w
Germline investigation in male breast cancer of DNA repair genes by next-generation sequencing Cite
Scarpitta R, Zanna I, Aretini P, Gambino G, Scatena C, Mei B, et al. Germline investigation in male breast cancer of DNA repair genes by next-generation sequencing. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2019; 178:557-564 10.1007/s10549-019-05429-z
Comorbidity and racial differences in risk of mortality of men with breast cancer. Cite
Parise C, Caggiano V. Comorbidity and racial differences in risk of mortality of men with breast cancer.. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2019; 37:1554-1554 10.1200/jco.2019.37.15_suppl.1554
Men’s Lived Experiences with Breast Cancer: The Double Consciousness of Marginal Men Cite
Thompson EH, Haydock AS. Men’s Lived Experiences with Breast Cancer: The Double Consciousness of Marginal Men. Sex Roles. Springer Science and Business Media LLC; 2019; 82:28-43 10.1007/s11199-019-01039-7
Male DCIS diagnosed after use of over-the-counter hormonal supplement Cite
Agbroko S, Rojas K, Manasseh D, Borgen P. Male DCIS diagnosed after use of over-the-counter hormonal supplement. International Journal of Surgery Case Reports. Elsevier BV; 2019; 57:60-62 10.1016/j.ijscr.2019.02.028
Is Breast-Conserving Therapy Appropriate for Male Breast Cancer Patients? A National Cancer Database Analysis Cite
Bateni SB, Davidson AJ, Arora M, Daly ME, Stewart SL, Bold RJ, et al. Is Breast-Conserving Therapy Appropriate for Male Breast Cancer Patients? A National Cancer Database Analysis. Annals of Surgical Oncology. Springer Science and Business Media LLC; 2019; 26:2144-2153 10.1245/s10434-019-07159-4
Abstract P6-19-06: Breast conservation surgery in male breast cancer: A systematic literature review Cite
Fisher C, de la Cruz L, Joshi S, Mah T, Blankenship S, Thiruchelvam P. Abstract P6-19-06: Breast conservation surgery in male breast cancer: A systematic literature review. Poster Session Abstracts. American Association for Cancer Research; 2019; 10.1158/1538-7445.sabcs18-p6-19-06
Management of Male Breast Cancer Cite
Gooch JC, Schnabel F. Management of Male Breast Cancer. Clinical Algorithms in General Surgery. Springer International Publishing; 2019;:113-116 10.1007/978-3-319-98497-1_30
Atypical ductal hyperplasia in men with gynecomastia: what is their breast cancer risk? Cite
Coopey SB, Kartal K, Li C, Yala A, Barzilay R, Faulkner HR, et al. Atypical ductal hyperplasia in men with gynecomastia: what is their breast cancer risk?. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2019; 175:1-4 10.1007/s10549-018-05117-4
Tamoxifen treatment for male breast cancer and risk of thromboembolism: prospective cohort analysis Cite
Eggemann H, Bernreiter A, Reinisch M, Loibl S, Taran F, Costa S, et al. Tamoxifen treatment for male breast cancer and risk of thromboembolism: prospective cohort analysis. British Journal of Cancer. Springer Science and Business Media LLC; 2019; 120:301-305 10.1038/s41416-018-0369-2
Characterization and prognosis of estrogen receptor-positive/progesterone receptor-negative male breast cancer: a population-based study Cite
Wei J, Zhang J, Fu D. Characterization and prognosis of estrogen receptor-positive/progesterone receptor-negative male breast cancer: a population-based study. World Journal of Surgical Oncology. Springer Science and Business Media LLC; 2018; 16 10.1186/s12957-018-1539-7
Overall Survival of Men and Women With Breast Cancer According to Tumor Subtype Cite
Leone J, Zwenger AO, Leone BA, Vallejo CT, Leone JP. Overall Survival of Men and Women With Breast Cancer According to Tumor Subtype. American Journal of Clinical Oncology. Ovid Technologies (Wolters Kluwer Health); 2019; 42:215-220 10.1097/coc.0000000000000497
Use and Effectiveness of Adjuvant Endocrine Therapy for Hormone Receptor–Positive Breast Cancer in Men Cite
Venigalla S, Carmona R, Guttmann DM, Jain V, Freedman GM, Clark AS, et al. Use and Effectiveness of Adjuvant Endocrine Therapy for Hormone Receptor–Positive Breast Cancer in Men. JAMA Oncology. American Medical Association (AMA); 2018; 4:e181114 10.1001/jamaoncol.2018.1114
Clinical features of patients with male breast cancer in Shanxi province of China from 2007 to 2016 Cite
Wang W, Xu X, Tian B, Wang Y, Du L, Sun T, et al. Clinical features of patients with male breast cancer in Shanxi province of China from 2007 to 2016. Journal of Investigative Medicine. BMJ; 2018; 67:699-705 10.1136/jim-2018-000823
Surgical options for male breast cancer Cite
Fentiman IS. Surgical options for male breast cancer. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2018; 172:539-544 10.1007/s10549-018-4952-2
Adjuvant tamoxifen adherence in men with early stage breast cancer. Cite
Oke O, Niu J, Chavez-MacGregor M, Zhao H, Giordano SH. Adjuvant tamoxifen adherence in men with early stage breast cancer.. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2018; 36:550-550 10.1200/jco.2018.36.15_suppl.550
“I Am Uncertain About What My Uncertainty Even Is”: Men’s Uncertainty and Information Management of Their BRCA-Related Cancer Risks Cite
Rauscher EA, Dean M, Campbell-Salome GM. “I Am Uncertain About What My Uncertainty Even Is”: Men’s Uncertainty and Information Management of Their BRCA-Related Cancer Risks. Journal of Genetic Counseling. Wiley; 2018; 27:1417-1427 10.1007/s10897-018-0276-y
Distribution of 21-Gene Recurrence Scores in Male Breast Cancer in the United States Cite
Altman AM, Kizy S, Yuan J, Denbo JW, Jensen EH, Hui JYC, et al. Distribution of 21-Gene Recurrence Scores in Male Breast Cancer in the United States. Annals of Surgical Oncology. Springer Science and Business Media LLC; 2018; 25:2296-2302 10.1245/s10434-018-6566-7
Evolving surgical treatment decisions for male breast cancer: an analysis of the National Surgical Quality Improvement Program (NSQIP) database Cite
Elmi M, Sequeira S, Azin A, Elnahas A, McCready DR, Cil TD. Evolving surgical treatment decisions for male breast cancer: an analysis of the National Surgical Quality Improvement Program (NSQIP) database. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2018; 171:427-434 10.1007/s10549-018-4830-y
The endocrinology of male breast cancer Cite
Fentiman IS. The endocrinology of male breast cancer. Endocrine-Related Cancer. Bioscientifica; 2018; 25:R365-R373 10.1530/erc-18-0117
Use and Effectiveness of Adjuvant Endocrine Therapy for Hormone Receptor–Positive Breast Cancer in Men Cite
Venigalla S, Carmona R, Guttmann DM, Jain V, Freedman GM, Clark AS, et al. Use and Effectiveness of Adjuvant Endocrine Therapy for Hormone Receptor–Positive Breast Cancer in Men. JAMA Oncology. American Medical Association (AMA); 2018; 4:e181114 10.1001/jamaoncol.2018.1114
Characterising the adipose-inflammatory microenvironment in male breast cancer Cite
Lees T, Cullinane A, Condon A, Shabaan AM, Humphries MP, Speirs V. Characterising the adipose-inflammatory microenvironment in male breast cancer. Endocrine-Related Cancer. Bioscientifica; 2018; 25:773-781 10.1530/erc-17-0407
Smoking and FGFR2 rs2981582 variant independently modulate male breast cancer survival: A population-based study in Tuscany, Italy Cite
Zanna I, Silvestri V, Palli D, Magrini A, Rizzolo P, Saieva C, et al. Smoking and FGFR2 rs2981582 variant independently modulate male breast cancer survival: A population-based study in Tuscany, Italy. The Breast. Elsevier BV; 2018; 40:85-91 10.1016/j.breast.2018.04.017
Gene-specific methylation profiles in BRCA-mutation positive and BRCA-mutation negative male breast cancers Cite
Rizzolo P, Silvestri V, Valentini V, Zelli V, Zanna I, Masala G, et al. Gene-specific methylation profiles in BRCA-mutation positive and BRCA-mutation negative male breast cancers. Oncotarget. Impact Journals, LLC; 2018; 9:19783-19792 10.18632/oncotarget.24856
Molecular Characterization and Mortality From Breast Cancer in Men Cite
Massarweh SA, Sledge GW, Miller DP, McCullough D, Petkov VI, Shak S. Molecular Characterization and Mortality From Breast Cancer in Men. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2018; 36:1396-1404 10.1200/jco.2017.76.8861
The 21-Gene Recurrence Score in Male Breast Cancer Cite
Turashvili G, Gonzalez-Loperena M, Brogi E, Dickler M, Norton L, Morrow M, et al. The 21-Gene Recurrence Score in Male Breast Cancer. Annals of Surgical Oncology. Springer Science and Business Media LLC; 2018; 25:1530-1535 10.1245/s10434-018-6411-z
Clinical and ultrasonographic features of male breast tumors: A retrospective analysis Cite
Yuan W, Li AF, Chou Y, Hsu H, Chen Y. Clinical and ultrasonographic features of male breast tumors: A retrospective analysis. PLOS ONE. Public Library of Science (PLoS); 2018; 13:e0194651 10.1371/journal.pone.0194651
Treatment Outcomes in Male Breast Cancer: A Retrospective Analysis of 161 Patients Cite
Wan B, Ganesh V, Zhang L, Sousa P, Drost L, Lorentz J, et al. Treatment Outcomes in Male Breast Cancer: A Retrospective Analysis of 161 Patients. Clinical Oncology. Elsevier BV; 2018; 30:354-365 10.1016/j.clon.2018.02.026
Occupational exposure to organic solvents and risk of male breast cancer: a European multicenter case-control study Cite
Laouali N, Pilorget C, Cyr D, Neri M, Kaerlev L, Sabroe S, et al. Occupational exposure to organic solvents and risk of male breast cancer: a European multicenter case-control study. Scandinavian Journal of Work, Environment & Health. Scandinavian Journal of Work, Environment and Health; 2018; 44:310-322 10.5271/sjweh.3717
Male BRCA mutation carriers: clinical characteristics and cancer spectrum Cite
Ibrahim M, Yadav S, Ogunleye F, Zakalik D. Male BRCA mutation carriers: clinical characteristics and cancer spectrum. BMC Cancer. Springer Science and Business Media LLC; 2018; 18 10.1186/s12885-018-4098-y
Does Prophylactic Radiation Therapy to Avoid Gynecomastia in Patients With Prostate Cancer Increase the Risk of Breast Cancer? Cite
Aksnessæther BY, Solberg A, Klepp OH, Myklebust TÅ, Skovlund E, Hoff SR, et al. Does Prophylactic Radiation Therapy to Avoid Gynecomastia in Patients With Prostate Cancer Increase the Risk of Breast Cancer?. International Journal of Radiation Oncology*Biology*Physics. Elsevier BV; 2018; 101:211-216 10.1016/j.ijrobp.2018.01.096
Finasteride treatment and male breast cancer: a register-based cohort study in four Nordic countries Cite
Meijer M, Thygesen LC, Green A, Emneus M, Brasso K, Iversen P, et al. Finasteride treatment and male breast cancer: a register-based cohort study in four Nordic countries. Cancer Medicine. Wiley; 2017; 7:254-260 10.1002/cam4.1273
Male breast cancer: correlation between immunohistochemical subtyping and PAM50 intrinsic subtypes, and the subsequent clinical outcomes Cite
Sánchez-Muñoz A, Vicioso L, Santonja A, Álvarez M, Plata-Fernández Y, Miramón J, et al. Male breast cancer: correlation between immunohistochemical subtyping and PAM50 intrinsic subtypes, and the subsequent clinical outcomes. Modern Pathology. Springer Science and Business Media LLC; 2017; 31:299-306 10.1038/modpathol.2017.129
Characterization of male breast cancer: results of the EORTC 10085/TBCRC/BIG/NABCG International Male Breast Cancer Program Cite
Cardoso F, Bartlett J, Slaets L, van Deurzen C, van Leeuwen-Stok E, Porter P, et al. Characterization of male breast cancer: results of the EORTC 10085/TBCRC/BIG/NABCG International Male Breast Cancer Program. Annals of Oncology. Elsevier BV; 2018; 29:405-417 10.1093/annonc/mdx651
Adolescent obesity and adult male breast cancer in a cohort of 1,382,093 men Cite
Keinan‐Boker L, Levine H, Leiba A, Derazne E, Kark JD. Adolescent obesity and adult male breast cancer in a cohort of 1,382,093 men. International Journal of Cancer. Wiley; 2017; 142:910-918 10.1002/ijc.31121
Treatment Outcomes and Prognostic Factors in Male Patients With Stage IV Breast Cancer: A Population-based Study Cite
Chen W, Huang Y, Lewis GD, Szeja SS, Hatch SS, Farach A, et al. Treatment Outcomes and Prognostic Factors in Male Patients With Stage IV Breast Cancer: A Population-based Study. Clinical Breast Cancer. Elsevier BV; 2018; 18:e97-e105 10.1016/j.clbc.2017.07.005
CHEK2 c.1100delC mutation is associated with an increased risk for male breast cancer in Finnish patient population Cite
Hallamies S, Pelttari LM, Poikonen-Saksela P, Jekunen A, Jukkola-Vuorinen A, Auvinen P, et al. CHEK2 c.1100delC mutation is associated with an increased risk for male breast cancer in Finnish patient population. BMC Cancer. Springer Science and Business Media LLC; 2017; 17 10.1186/s12885-017-3631-8
Increased risk of arterial thromboembolism in older men with breast cancer Cite
Reiner AS, Navi BB, DeAngelis LM, Panageas KS. Increased risk of arterial thromboembolism in older men with breast cancer. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2017; 166:903-910 10.1007/s10549-017-4433-z
Familial associations of male breast cancer with other cancers Cite
Zheng G, Yu H, Hemminki A, Försti A, Sundquist K, Hemminki K. Familial associations of male breast cancer with other cancers. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2017; 166:897-902 10.1007/s10549-017-4468-1
Male Breast Cancer as a Second Primary Cancer: Increased Risk Following Lymphoma Cite
Farr DE, Thomas A, Khan SA, Schroeder MC. Male Breast Cancer as a Second Primary Cancer: Increased Risk Following Lymphoma. The Oncologist. Wiley; 2017; 22:895-900 10.1634/theoncologist.2016-0460
Abstract 249: Dietary supplementation with methylseleninic acid reduces male mammary tumorigenesis in MMTV-PyMT mice Cite
Sundaram S. Abstract 249: Dietary supplementation with methylseleninic acid reduces male mammary tumorigenesis in MMTV-PyMT mice. Prevention Research. American Association for Cancer Research; 2017; 10.1158/1538-7445.am2017-249
Hormone Receptor-Positive Breast Cancer Has a Worse Prognosis in Male Than in Female Patients Cite
Li X, Yang J, Krishnamurti U, Huo L, Ward KC, O'Regan R, et al. Hormone Receptor-Positive Breast Cancer Has a Worse Prognosis in Male Than in Female Patients. Clinical Breast Cancer. Elsevier BV; 2017; 17:356-366 10.1016/j.clbc.2017.03.005
Family history of breast cancer in non-BRCA male breast cancer: A case-control study. Cite
Calip GS, Exten KR, Rauscher GH, Brown K, Bernhisel R, Kidd J, et al. Family history of breast cancer in non-BRCA male breast cancer: A case-control study.. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2017; 35:e13032-e13032 10.1200/jco.2017.35.15_suppl.e13032
Pathological characterisation of male breast cancer: Results of the EORTC 10085/TBCRC/BIG/NABCG International Male Breast Cancer Program Cite
Vermeulen MA, Slaets L, Cardoso F, Giordano SH, Tryfonidis K, van Diest PJ, et al. Pathological characterisation of male breast cancer: Results of the EORTC 10085/TBCRC/BIG/NABCG International Male Breast Cancer Program. European Journal of Cancer. Elsevier BV; 2017; 82:219-227 10.1016/j.ejca.2017.01.034
Postmastectomy Radiation Therapy Is Associated With Improved Survival in Node-Positive Male Breast Cancer: A Population Analysis Cite
Abrams MJ, Koffer PP, Wazer DE, Hepel JT. Postmastectomy Radiation Therapy Is Associated With Improved Survival in Node-Positive Male Breast Cancer: A Population Analysis. International Journal of Radiation Oncology*Biology*Physics. Elsevier BV; 2017; 98:384-391 10.1016/j.ijrobp.2017.02.007
Male Breast Cancer Cite
Serdy KM, Leone JP, Dabbs DJ, Bhargava R. Male Breast Cancer. American Journal of Clinical Pathology. Oxford University Press (OUP); 2017;:aqw207 10.1093/ajcp/aqw207
Male Breast Cancer Incidence and Mortality Risk in the Japanese Atomic Bomb Survivors – Differences in Excess Relative and Absolute Risk from Female Breast Cancer Cite
Little MP, McElvenny DM. Male Breast Cancer Incidence and Mortality Risk in the Japanese Atomic Bomb Survivors – Differences in Excess Relative and Absolute Risk from Female Breast Cancer. Environmental Health Perspectives. Environmental Health Perspectives; 2017; 125:223-229 10.1289/ehp151
Male breast cancer precursor lesions: analysis of the EORTC 10085/TBCRC/BIG/NABCG International Male Breast Cancer Program Cite
Doebar SC, Slaets L, Cardoso F, Giordano SH, Bartlett JM, Tryfonidis K, et al. Male breast cancer precursor lesions: analysis of the EORTC 10085/TBCRC/BIG/NABCG International Male Breast Cancer Program. Modern Pathology. Springer Science and Business Media LLC; 2017; 30:509-518 10.1038/modpathol.2016.229
Impact of Primary Tumor Surgery in Stage IV Male Breast Cancer Cite
Muzaffar M, Kachare S, Vohra N. Impact of Primary Tumor Surgery in Stage IV Male Breast Cancer. Clinical Breast Cancer. Elsevier BV; 2017; 17:e143-e149 10.1016/j.clbc.2016.11.001
Male breast cancer in a multi-gene panel testing cohort: insights and unexpected results Cite
Pritzlaff M, Summerour P, McFarland R, Li S, Reineke P, Dolinsky JS, et al. Male breast cancer in a multi-gene panel testing cohort: insights and unexpected results. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2016; 161:575-586 10.1007/s10549-016-4085-4
Eribulin in Male Patients With Breast Cancer: The First Report of Clinical Outcomes Cite
Giotta F, Acito L, Candeloro G, Del Medico P, Gadaleta‐Caldarola G, Giordano G, et al. Eribulin in Male Patients With Breast Cancer: The First Report of Clinical Outcomes. The Oncologist. Wiley; 2016; 21:1298-1305 10.1634/theoncologist.2016-0022
Prognostic models in male breast cancer Cite
van der Pol CC, Lacle MM, Witkamp AJ, Kornegoor R, Miao H, Bouchardy C, et al. Prognostic models in male breast cancer. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2016; 160:339-346 10.1007/s10549-016-3991-9
Poorer breast cancer survival outcomes in males than females might be attributable to tumor subtype Cite
Wu Q, Li J, Zhu S, Wu J, Li X, Liu Q, et al. Poorer breast cancer survival outcomes in males than females might be attributable to tumor subtype. Oncotarget. Impact Journals, LLC; 2016; 7:87532-87542 10.18632/oncotarget.12052
Special considerations in the evaluation and management of breast cancer in men11This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors. Cite
Massarweh SA, Choi GL. Special considerations in the evaluation and management of breast cancer in men11This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.. Current Problems in Cancer. Elsevier BV; 2016; 40:163-171 10.1016/j.currproblcancer.2016.09.003
Paget's disease of the male breast in the 21st century: A systematic review Cite
Adams SJ, Kanthan R. Paget's disease of the male breast in the 21st century: A systematic review. The Breast. Elsevier BV; 2016; 29:14-23 10.1016/j.breast.2016.06.015
Long-term survival and BRCA status in male breast cancer: a retrospective single-center analysis Cite
Gargiulo P, Pensabene M, Milano M, Arpino G, Giuliano M, Forestieri V, et al. Long-term survival and BRCA status in male breast cancer: a retrospective single-center analysis. BMC Cancer. Springer Science and Business Media LLC; 2016; 16 10.1186/s12885-016-2414-y
Patterns of recurrence and treatment in male breast cancer: A clue to prognosis? Cite
Henriques Abreu M, Henriques Abreu P, Afonso N, Pereira D, Henrique R, Lopes C. Patterns of recurrence and treatment in male breast cancer: A clue to prognosis?. International Journal of Cancer. Wiley; 2016; 139:1715-1720 10.1002/ijc.30225
Is Breast Conserving Therapy a Safe Modality for Early-Stage Male Breast Cancer? Cite
Zaenger D, Rabatic BM, Dasher B, Mourad WF. Is Breast Conserving Therapy a Safe Modality for Early-Stage Male Breast Cancer?. Clinical Breast Cancer. Elsevier BV; 2016; 16:101-104 10.1016/j.clbc.2015.11.005
Male breast cancer: Medical and psychological management in comparison to female breast cancer. A review Cite
da Silva TL. Male breast cancer: Medical and psychological management in comparison to female breast cancer. A review. Cancer Treatment Communications. Elsevier BV; 2016; 7:23-34 10.1016/j.ctrc.2016.03.004
Risk of Second Non-Breast Primary Cancer in Male and Female Breast Cancer Patients: A Population-Based Cohort Study Cite
Hung M, Liu C, Teng C, Hu Y, Yeh C, Chen S, et al. Risk of Second Non-Breast Primary Cancer in Male and Female Breast Cancer Patients: A Population-Based Cohort Study. PLOS ONE. Public Library of Science (PLoS); 2016; 11:e0148597 10.1371/journal.pone.0148597
Male breast cancer is not congruent with the female disease Cite
Fentiman IS. Male breast cancer is not congruent with the female disease. Critical Reviews in Oncology/Hematology. Elsevier BV; 2016; 101:119-124 10.1016/j.critrevonc.2016.02.017
Male breast cancer in BRCA1 and BRCA2 mutation carriers: pathology data from the Consortium of Investigators of Modifiers of BRCA1/2 Cite
Silvestri V, Barrowdale D, Mulligan AM, Neuhausen SL, Fox S, Karlan BY, et al. Male breast cancer in BRCA1 and BRCA2 mutation carriers: pathology data from the Consortium of Investigators of Modifiers of BRCA1/2. Breast Cancer Research. Springer Science and Business Media LLC; 2016; 18 10.1186/s13058-016-0671-y
Occupational exposure to magnetic fields and breast cancer among Canadian men Cite
Grundy A, Harris SA, Demers PA, Johnson KC, Agnew DA, Villeneuve PJ. Occupational exposure to magnetic fields and breast cancer among Canadian men. Cancer Medicine. Wiley; 2016; 5:586-596 10.1002/cam4.581
Male breast cancer: Looking for better prognostic subgroups Cite
Abreu MH, Afonso N, Abreu PH, Menezes F, Lopes P, Henrique R, et al. Male breast cancer: Looking for better prognostic subgroups. The Breast. Elsevier BV; 2016; 26:18-24 10.1016/j.breast.2015.12.001
Optimal delivery of male breast cancer follow-up care: improving outcomes Cite
Ruddy K, Ferzoco R. Optimal delivery of male breast cancer follow-up care: improving outcomes. Breast Cancer: Targets and Therapy. Informa UK Limited; 2015;:371 10.2147/bctt.s75630
Smoking and survival in male breast cancer patients Cite
Padron-Monedero A, Koru-Sengul T, Tannenbaum SL, Miao F, Hansra D, Lee DJ, et al. Smoking and survival in male breast cancer patients. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2015; 153:679-687 10.1007/s10549-015-3582-1
A Prognostic Analysis of Male Breast Cancer (MBC) Compared with Post-Menopausal Female Breast Cancer (FBC) Cite
Yu X, Yang H, Yu Y, Zou D, Miao L. A Prognostic Analysis of Male Breast Cancer (MBC) Compared with Post-Menopausal Female Breast Cancer (FBC). PLOS ONE. Public Library of Science (PLoS); 2015; 10:e0136670 10.1371/journal.pone.0136670
Androgen receptor and antiandrogen therapy in male breast cancer Cite
Di Lauro L, Barba M, Pizzuti L, Vici P, Sergi D, Di Benedetto A, et al. Androgen receptor and antiandrogen therapy in male breast cancer. Cancer Letters. Elsevier BV; 2015; 368:20-25 10.1016/j.canlet.2015.07.040
Prediagnostic Sex Steroid Hormones in Relation to Male Breast Cancer Risk Cite
Brinton LA, Key TJ, Kolonel LN, Michels KB, Sesso HD, Ursin G, et al. Prediagnostic Sex Steroid Hormones in Relation to Male Breast Cancer Risk. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2015; 33:2041-2050 10.1200/jco.2014.59.1602
CYP2D6*4 polymorphism: A new marker of response to hormonotherapy in male breast cancer? Cite
Abreu M, Gomes M, Menezes F, Afonso N, Abreu P, Medeiros R, et al. CYP2D6*4 polymorphism: A new marker of response to hormonotherapy in male breast cancer?. The Breast. Elsevier BV; 2015; 24:481-486 10.1016/j.breast.2015.04.010
Black/White Disparities in Receipt of Treatment and Survival Among Men With Early-Stage Breast Cancer Cite
Sineshaw HM, Freedman RA, Ward EM, Flanders WD, Jemal A. Black/White Disparities in Receipt of Treatment and Survival Among Men With Early-Stage Breast Cancer. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2015; 33:2337-2344 10.1200/jco.2014.60.5584
Disparities in Overall Survival for Male Breast Cancer Patients in the State of Florida (1996-2007) Cite
O'Brien B, Koru-Sengul T, Miao F, Saclarides C, Tannenbaum SL, Alghamdi H, et al. Disparities in Overall Survival for Male Breast Cancer Patients in the State of Florida (1996-2007). Clinical Breast Cancer. Elsevier BV; 2015; 15:e177-e187 10.1016/j.clbc.2014.12.010
Clinicopathologic characteristics of breast cancer in BRCA-carriers and non-carriers in women 35 years of age or less Cite
Bayraktar S, Amendola L, Gutierrez-Barrera AM, Hashmi SS, Amos C, Gambello M, et al. Clinicopathologic characteristics of breast cancer in BRCA-carriers and non-carriers in women 35 years of age or less. The Breast. Elsevier BV; 2014; 23:770-774 10.1016/j.breast.2014.08.010
Metastatic Male Breast Cancer: A Retrospective Cohort Analysis Cite
Foerster R, Schroeder L, Foerster F, Wulff V, Schubotz B, Baaske D, et al. Metastatic Male Breast Cancer: A Retrospective Cohort Analysis. Breast Care. S. Karger AG; 2014; 9:267-271 10.1159/000365953
The 21-Gene Recurrence Score Assay (Oncotype DX) in Estrogen Receptor-Positive Male Breast Cancer: Experience in an Israeli Cohort Cite
Grenader T, Yerushalmi R, Tokar M, Fried G, Kaufman B, Peretz T, et al. The 21-Gene Recurrence Score Assay (Oncotype DX) in Estrogen Receptor-Positive Male Breast Cancer: Experience in an Israeli Cohort. Oncology. S. Karger AG; 2014; 87:1-6 10.1159/000360793
Outcome of Male Breast Cancer: A Matched Single-Institution Series Cite
Iorfida M, Bagnardi V, Rotmensz N, Munzone E, Bonanni B, Viale G, et al. Outcome of Male Breast Cancer: A Matched Single-Institution Series. Clinical Breast Cancer. Elsevier BV; 2014; 14:371-377 10.1016/j.clbc.2014.02.008
Prenatal Bisphenol A exposure delays the development of the male rat mammary gland Cite
Kass L, Durando M, Altamirano GA, Manfroni-Ghibaudo GE, Luque EH, Muñoz-de-Toro M. Prenatal Bisphenol A exposure delays the development of the male rat mammary gland. Reproductive Toxicology. Elsevier BV; 2015; 54:37-46 10.1016/j.reprotox.2014.02.001
Anthropometric and Hormonal Risk Factors for Male Breast Cancer: Male Breast Cancer Pooling Project Results Cite
Brinton LA, Cook MB, McCormack V, Johnson KC, Olsson H, Casagrande JT, et al. Anthropometric and Hormonal Risk Factors for Male Breast Cancer: Male Breast Cancer Pooling Project Results. JNCI Journal of the National Cancer Institute. Oxford University Press (OUP); 2014; 106:djt465-djt465 10.1093/jnci/djt465
Male Breast Cancer: 20-Year Survival Data for Post-Mastectomy Radiotherapy Cite
Eggemann H, Ignatov A, Stabenow R, von Minckwitz G, Röhl FW, Hass P, et al. Male Breast Cancer: 20-Year Survival Data for Post-Mastectomy Radiotherapy. Breast Care. S. Karger AG; 2013; 8:270-275 10.1159/000354122
Poorer Survival of Male Breast Cancer Compared with Female Breast Cancer Patients May Be Due to Biological Differences Cite
Chen X, Liu X, Zhang L, Li S, Shi Y, Tong Z. Poorer Survival of Male Breast Cancer Compared with Female Breast Cancer Patients May Be Due to Biological Differences. Japanese Journal of Clinical Oncology. Oxford University Press (OUP); 2013; 43:954-963 10.1093/jjco/hyt116
Differential Expression of Growth Factor Receptors and Membrane-Bound Tumor Markers for Imaging in Male and Female Breast Cancer Cite
Vermeulen JF, Kornegoor R, van der Wall E, van der Groep P, van Diest PJ. Differential Expression of Growth Factor Receptors and Membrane-Bound Tumor Markers for Imaging in Male and Female Breast Cancer. PLoS ONE. Public Library of Science (PLoS); 2013; 8:e53353 10.1371/journal.pone.0053353
Tamoxifen adherence and its relationship to mortality in 116 men with breast cancer Cite
Xu S, Yang Y, Tao W, Song Y, Chen Y, Ren Y, et al. Tamoxifen adherence and its relationship to mortality in 116 men with breast cancer. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2012; 136:495-502 10.1007/s10549-012-2286-z
Prediction of axillary lymph node status in male breast carcinoma Cite
Vaysse C, Sroussi J, Mallon P, Feron J, Rivain A, Ngo C, et al. Prediction of axillary lymph node status in male breast carcinoma. Annals of Oncology. Elsevier BV; 2013; 24:370-376 10.1093/annonc/mds283
Male Breast Cancer: Immunohistochemical Subtypes and Clinical Outcome Characterization Cite
Sánchez-Muñoz A, Román-Jobacho A, Pérez-Villa L, Sánchez-Rovira P, Miramón J, Pérez D, et al. Male Breast Cancer: Immunohistochemical Subtypes and Clinical Outcome Characterization. Oncology. S. Karger AG; 2012; 83:228-233 10.1159/000341537
Health-related quality of life in breast cancer patients: A bibliographic review of the literature from 1974 to 2007 Cite
Montazeri A. Health-related quality of life in breast cancer patients: A bibliographic review of the literature from 1974 to 2007. Journal of Experimental & Clinical Cancer Research. Springer Science and Business Media LLC; 2008; 27 10.1186/1756-9966-27-32
Impact of X Chromosome Genes in Explaining the Excess Risk of Cancer in Males Cite
Biggar RJ, Bergen AW, Poulsen GN. Impact of X Chromosome Genes in Explaining the Excess Risk of Cancer in Males. American Journal of Epidemiology. Oxford University Press (OUP); 2009; 170:65-71 10.1093/aje/kwp083
Risk of breast cancer in families of multiple affected women and men Cite
Bevier M, Sundquist K, Hemminki K. Risk of breast cancer in families of multiple affected women and men. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2011; 132:723-728 10.1007/s10549-011-1915-2
Risk of breast cancer in male BRCA2 carriers Cite
Evans DGR, Susnerwala I, Dawson J, Woodward E, Maher ER, Lalloo F. Risk of breast cancer in male BRCA2 carriers. Journal of Medical Genetics. BMJ; 2010; 47:710-711 10.1136/jmg.2009.075176
Male breast cancer in veteran population: Retrospective analysis of VACCR database. Cite
Subbiah S, Tashi T, Gonsalves W, Kalaiah M, Didwaniya N, Thota R, et al. Male breast cancer in veteran population: Retrospective analysis of VACCR database.. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2010; 28:1031-1031 10.1200/jco.2010.28.15_suppl.1031
Risk Factors for Male Breast Cancer?A Case-Control Study from Scandinavia Cite
Marianne Ewertz LH. Risk Factors for Male Breast Cancer?A Case-Control Study from Scandinavia. Acta Oncologica. Informa UK Limited; 2001; 40:467-471 10.1080/02841860117406
Progression from Normal Breast Pathology to Breast Cancer Is Associated with Increasing Prevalence of Mouse Mammary Tumor Virus-Like Sequences in Men and Women Cite
Ford CE, Faedo M, Crouch R, Lawson JS, Rawlinson WD. Progression from Normal Breast Pathology to Breast Cancer Is Associated with Increasing Prevalence of Mouse Mammary Tumor Virus-Like Sequences in Men and Women. Cancer Research. American Association for Cancer Research (AACR); 2004; 64:4755-4759 10.1158/0008-5472.can-03-3804